Qrem Cytokine

QREM is a Spanish medical technology company specializing in the development of point-of-care regenerative medicine solutions. The company's flagship product, QREM Cytokine, is a patented "lab-in-a-box" device that enables clinicians to prepare Cytokine-Rich Serum (CRS) from a patient's own blood in approximately 30 minutes. This autologous therapy is designed to treat osteoarthritis and musculoskeletal pathologies by delivering a high concentration of anti-inflammatory cytokines and growth factors directly to the affected area. By automating the complex laboratory process, QREM provides a scalable and standardized alternative to traditional platelet-rich plasma (PRP) and interleukin-1 receptor antagonist (IL-1Ra) therapies.